ID: ALA2409350

Max Phase: Preclinical

Molecular Formula: C19H16O6

Molecular Weight: 340.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOc1cc(O)c2c(=O)cc(-c3ccc4c(c3)OCCO4)oc2c1

Standard InChI:  InChI=1S/C19H16O6/c1-2-22-12-8-13(20)19-14(21)10-16(25-18(19)9-12)11-3-4-15-17(7-11)24-6-5-23-15/h3-4,7-10,20H,2,5-6H2,1H3

Standard InChI Key:  JJHMXDAHWPCYMT-UHFFFAOYSA-N

Associated Targets(non-human)

Aldose reductase 1045 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 340.33Molecular Weight (Monoisotopic): 340.0947AlogP: 3.34#Rotatable Bonds: 3
Polar Surface Area: 78.13Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.36CX Basic pKa: CX LogP: 3.03CX LogD: 2.71
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.79Np Likeness Score: 0.45

References

1. Wang QQ, Cheng N, Zheng XW, Peng SM, Zou XQ..  (2013)  Synthesis of organic nitrates of luteolin as a novel class of potent aldose reductase inhibitors.,  21  (14): [PMID:23683835] [10.1016/j.bmc.2013.04.066]

Source